TET2 and atherosclerosis: In recent years, there has been a growing interest in CHIP due to TET-2 loss of function variants because preclinical studies have suggested that Tet2 loss of function in myeloid cells, and the subsequent increase in IL-1 β-related signaling, act as accelerators of atherosclerosis [99].